22
Participants
Start Date
August 31, 2012
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Placebo pill
Subjects will receive a sugar pill (in combination with room air) during their placebo arm studies
Sedative
Subjects will receive eszopiclone (in combination with medical oxygen) during their treatment arm studies
Room air
Subjects will receive room air (in combination with a sugar pill) during their placebo arm studies
Oxygen
Subjects will receive medical grade oxygen (in combination with eszopiclone) during their treatment arm studies
Brigham and Women's Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Brigham and Women's Hospital
OTHER